/* ]]> */
Vice President of Health, Science and Technology
As Vice President of Health, Science and Technology, Dr. Brian Erkkila spearheads the Foundation’s efforts to support actionable research about tobacco, nicotine, cessation, and harm reduction.
This involves advancing our research agenda through identification of research gaps and recruiting innovative investigators to address them, strengthening global research capacity where most smokers live, facilitating funding models to drive more effective cessation therapies, and monitoring perceptions around smoking, tobacco harm reduction and nicotine.
Prior to joining the Foundation, Dr. Erkkila served for seven years at the FDA Center for Tobacco Products (CTP), where he was instrumental in the development of the tobacco product review process and CTP research priorities, with a particular focus on developing a tobacco product quantitative risk assessment program. As an expert in evaluating scientific data concerning tobacco products and their impact on individuals and populations, Dr. Erkkila was responsible for providing the scientific basis for the development of tobacco policy, guidance, and regulation.
A neurobiologist by training, Dr. Erkkila did his post-doc examining hippocampal function and development at the National Institute of Child and Human Development’s (NICHD) Laboratory of Cellular and Synaptic Neurophysiology under the mentorship of Dr. Chris McBain.
Dr. Erkkila is based in Washington, DC. He holds a PhD in Neurobiology from the University of Alabama at Birmingham and a BA in Neuroscience from Johns Hopkins University.